Insurance News & Info

By Atossa Araxia Abrahamian NEW YORK (Reuters) – Up to 20 percent of children in the United States suffer from a mental disorder, and the number of kids diagnosed with one has been rising for more than a decade, according to a report released on T… View full post on Yahoo! Health News

By Andrew M. Seaman NEW YORK (Reuters Health) – Children born after being exposed to the flu during pregnancy may have a nearly four-fold higher risk of later developing bipolar disorder, according to a small new study. The senior researcher said … View full post on Yahoo! Health News

By Kerry Grens NEW YORK (Reuters Health) – In a review of data covering 13 years and millions of patients, researchers found no evidence of a link between being vaccinated against tetanus, hepatitis, pneumonia or flu, and developing the nerve-dege… View full post on Yahoo! Health News

LONDON (Reuters) – GlaxoSmithKline's Pandemrix swine flu vaccine has been linked to cases of the rare sleep disorder narcolepsy in children in a scientific study in England that confirms similar findings elsewhere in Europe. The vaccine, more … View full post on Yahoo! Health News

(Reuters) – U.S. health regulators on Friday approved a drug from Hyperion Therapeutics Inc designed to remove ammonia buildup from the blood of patients with enzyme deficiencies known as urea cycle disorders. The drug, to be sold under the brand … View full post on Yahoo! Health News

LONDON (Reuters) – A drug for bipolar disorder that works like lithium – the most common and effective treatment – but without lithium's side-effects has been identified by British researchers in tests on mice. Scientists say the drug, ebselen… View full post on Yahoo! Health News

NEW YORK (Reuters) – "Too Bright to Hear Too Loud to See" is a work of fiction, but author Juliann Garey said the protagonist's struggles with bipolar disorder are based on her own reality. The debut novel from journalist and screenw… View full post on Yahoo! Health News

(Reuters) – Transcept Pharmaceuticals Inc said a mid-stage trial of its experimental drug for obsessive compulsive disorder did not meet the main goal of showing improvements in treating symptoms better than a placebo. The company expects to compl… View full post on Yahoo! Health News

(Reuters) – Vanda Pharmaceuticals Inc said a late-stage trial of its drug for treating a rare disorder affecting blind people met the main goal of showing improvement over a placebo. The drug, tasimelteon, was being tested as a treatment for non-2… View full post on Yahoo! Health News

NEW YORK (Reuters Health) – Women who have a hormone disorder called polycystic ovary syndrome (PCOS) and who take the birth control pill have twice the risk of blood clots than do other women on the Pill, according to a new study. "For many … View full post on Yahoo! Health News